Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.390
-0.075 (-1.68%)
At close: Jun 26, 2026, 4:00 PM EDT
4.400
+0.010 (0.23%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Aquestive Therapeutics Employees
Aquestive Therapeutics had 147 employees as of December 31, 2025. The number of employees increased by 5 or 3.52% compared to the previous year.
Employees
147
Change (1Y)
5
Growth (1Y)
3.52%
Revenue / Employee
$341,980
Profits / Employee
-$468,782
Market Cap
550.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Evolus | 350 |
| Esperion Therapeutics | 294 |
AQST News
- 1 day ago - Aquestive Therapeutics files to sell 230,271 shares of common stock for holders - TheFly
- 2 days ago - Aquestive Therapeutics Registration statement: Registration filing - Filings
- 18 days ago - Aquestive Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Aquestive Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Aquestive Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Aquestive Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Aquestive Therapeutics Slides: Q1 2026 - Filings
- 6 weeks ago - Aquestive Therapeutics reports Q1 EPS (7c), consensus (13c) - TheFly